U.S. Anti-Allergic Therapies Markets

 

Regular Price: USD 2,450

Special Price USD 1,715

30% OFF

* Required Fields

Regular Price: USD 2,450

Special Price USD 1,715

PAY BY INVOICE

Be the first to review this product

This report analyzes the U.S. anti-allergic therapies markets, for the forecast period 2000 to 2010. The report is segmented into 5 chapters viz. Executive Summary, Total Market, Prescription Antihistamines Market, Prescription Corticosteroids Market, and OTC Allergy Drugs Market. Each segment provides revenue forecasts, market share, pricing trends, demand analysis, competitive structure and market and product trends. Drivers, restraints and challenges and the strategic recommendations are also discussed. Frost & Sullivan Awards are conferred on deserving companies.

Table of Contents

U.S. Anti-Allergic Therapies Markets, Executive SummaryExecutive SummaryExecutive SummaryU.S. Anti-Allergic Therapies Markets, Total MarketScope and MethodologyReport Scope and SegmentationResearch MethodologyMarket OverviewIntroductionMarket Engineering AnalysisMarket Demand & ForecastsCompetitive AnalysisMarket ChallengesIndustry IssuesFrost & Sullivan AwardsResearch & Development Strategy Leadership AwardMarket Penetration AwardProduct Launch Strategy AwardU.S. Anti-Allergic Therapies Markets, Prescription Antihistamines MarketSegment HighlightsSegment HighlightsOverviewIntroductionMarket Engineering AnalysisSegment ChallengesIndustry IssuesMarket Demand and ForecastsRevenue ForecastsPatient ForecastsMarket TrendsFactors Affecting Market GrowthProduct TrendsPricing Analysis and TrendsMarket Share AnalysisCompetitive AnalysisCompetitive LandscapeAlcon LaboratoriesAventisMedPointe PharmaceuticalsPfizerSchering-PloughU.S. Anti-Allergic Therapies Markets, Prescription Corticosteroids MarketSegment HighlightsSegment HighlightsOverviewIntroductionMarket Engineering AnalysisSegment ChallengesIndustry IssuesMarket Demand and ForecastsRevenue ForecastsPatient ForecastsMarket TrendsFactors Affecting Market GrowthProduct TrendsPricing TrendsMarket Share AnalysisCompetitive AnalysisCompetitive LandscapeAstraZenecaAventisCollegium PharmaceuticalGlaxoSmithKlineIvax PharmaceuticalsSchering-PloughU.S. Anti-Allergic Therapies Markets, Over the Counter (OTC) Allergy Drugs MarketSegment HighlightsSegment HighlightsOverviewIntroductionMarket Engineering AnalysisSegment ChallengesIndustry IssuesMarket Demand and ForecastsRevenue ForecastsPatient ForecastsMarket TrendsFactors Affecting Market GrowthProduct TrendsPricing TrendsMarket Share AnalysisCompetitive AnalysisCompetitive LandscapeJohnson & JohnsonLeiner Health ProductsNovartisPfizerSchering-PloughWyethU.S. Anti-Allergic Therapies Markets, AppendixDecision Support DatabaseNumber of PhysiciansNumber of General PractitionersFemale PopulationMale PopulationTotal Healthcare Expenditure




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 22-Nov-17

Region : North America

Release Date : 21-Nov-17

Region : North America

Release Date : 20-Nov-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.